David Rosa's most recent trade in Intuitive Surgical Inc was a trade of 5,454 Common Stock done . Disclosure was reported to the exchange on Nov. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intuitive Surgical | David J. Rosa | Director, Chief Executive Officer (CEO) | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Nov 2025 | 5,454 | 228,802 (0%) | 0% | 0 | Common Stock | |
| Eastern Bankshares Inc | R. David Rosato | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 17.08 per share. | 28 Oct 2025 | 10,000 | 30,000 | - | 17.1 | 170,800 | Common Stock |
| Eastern Bankshares Inc | R. David Rosato | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 16.88 per share. | 28 Oct 2025 | 10,000 | 40,000 | - | 16.9 | 168,800 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2025 | 27,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical | David J. Rosa | Director, Chief Executive Officer (CEO) | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.64 per share. | 24 Oct 2025 | 27,000 | 258,756 (0%) | 0% | 79.6 | 2,150,221 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, Chief Executive Officer (CEO) | Sale of securities on an exchange or to another person at price $ 547.55 per share. | 24 Oct 2025 | 24,500 | 234,256 (0%) | 0% | 547.6 | 13,414,980 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 30 Sep 2025 | 2,458 | 1,156,373 | - | 0.9 | 2,184 | Common Stock |
| Eastern Bankshares Inc | R. David Rosato | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 11,356 | 22,714 | - | - | Restricted Stock Units | |
| Eastern Bankshares Inc | R. David Rosato | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2025 | 11,356 | 11,356 | - | 0 | Common Stock | |
| Eastern Bankshares Inc | R. David Rosato | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.02 per share. | 03 Sep 2025 | 3,334 | 8,022 | - | 17.0 | 56,745 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, Chief Executive Officer (CEO) | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2025 | 7,640 | 7,640 | - | - | Restricted Stock Units | |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. | 30 Jun 2025 | 2,458 | 1,158,831 | - | 0.7 | 1,667 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 1,358 | 2,716 | - | - | Restricted Stock Units - 6-12-23 | |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2025 | 1,358 | 232,430 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 526.15 per share. | 10 Jun 2025 | 674 | 231,756 (0%) | 0% | 526.1 | 354,625 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, President | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2025 | 851 | 231,072 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 750,000 | 750,000 | - | - | Option to Purchase Common Stock | |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 04 Apr 2025 | 100,000 | 1,161,289 | - | 0.5 | 50,000 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.85 per share. | 31 Mar 2025 | 2,458 | 1,061,289 | - | 0.9 | 2,090 | Common Stock |
| Eastern Bankshares Inc | R. David Rosato | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 15.40 per share. | 11 Mar 2025 | 10,000 | 20,000 | - | 15.4 | 154,000 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.00 per share. | 05 Mar 2025 | 14,625 | 233,807 (0%) | 0% | 77.0 | 1,126,109 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 14,625 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Mar 2025 | 14,625 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.46 per share. | 05 Mar 2025 | 14,625 | 240,063 (0%) | 0% | 59.5 | 869,635 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, President | Sale of securities on an exchange or to another person at price $ 557.47 per share. | 05 Mar 2025 | 8,369 | 225,438 (0%) | 0% | 557.5 | 4,665,452 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, President | Sale of securities on an exchange or to another person at price $ 557.58 per share. | 05 Mar 2025 | 8,140 | 231,923 (0%) | 0% | 557.6 | 4,538,691 | Common Stock |
| Eastern Bankshares Inc | R. David Rosato | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 12,408 | 12,408 | - | - | Restricted Stock Units | |
| Intuitive Surgical | David J. Rosa | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 7,518 | 222,153 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 3,729 | 219,182 (0%) | 0% | 563.8 | 2,102,298 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,504 | 1,503 | - | - | Restricted Stock Units | |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 1,504 | 223,657 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 563.77 per share. | 27 Feb 2025 | 746 | 222,911 (0%) | 0% | 563.8 | 420,572 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 9,155 | 9,155 | - | - | Restricted Stock Units - 2-26-2025 | |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 3,816 | 11,447 | - | - | Restricted Stock Units - 2-26-2024 | |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 3,816 | 216,527 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 573.74 per share. | 26 Feb 2025 | 1,892 | 214,635 (0%) | 0% | 573.7 | 1,085,516 | Common Stock |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,710 | 0 | - | - | Restricted Stock Units | |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,710 | 213,559 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 573.74 per share. | 26 Feb 2025 | 848 | 212,711 (0%) | 0% | 573.7 | 486,532 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.16 per share. | 18 Feb 2025 | 71,325 | 1,063,747 | - | 1.2 | 82,737 | Common Stock |
| BioRestorative Therapies Inc | David A. Rosa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 52,632 | 52,632 | - | - | Stock Option | |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 1,437 | 2,872 | - | - | Restricted Stock Units - 2-28-2023 | |
| Intuitive Surgical | David J. Rosa | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2025 | 1,437 | 212,572 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David J. Rosa | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 582.98 per share. | 10 Feb 2025 | 723 | 211,849 (0%) | 0% | 583.0 | 421,495 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 31 Jan 2025 | 2,239 | 1,135,072 | - | 1.2 | 2,575 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. | 31 Dec 2024 | 4,697 | 1,137,311 | - | 0.8 | 3,880 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.62 per share. | 30 Nov 2024 | 2,239 | 1,142,008 | - | 0.6 | 1,395 | Common Stock |
| Intuitive Surgical | David J. Rosa | President | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Nov 2024 | 915 | 211,080 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David J. Rosa | President | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2024 | 1,980 | 211,995 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David J. Rosa | President | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2024 | 1,980 | 213,975 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.97 per share. | 31 Oct 2024 | 2,239 | 1,144,247 | - | 1.0 | 2,172 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.99 per share. | 30 Sep 2024 | 4,697 | 1,146,486 | - | 1.0 | 4,650 | Common Stock |
| Eastern Bankshares Inc | R. David Rosato | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 34,070 | 34,070 | - | - | Restricted Stock Unit | |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 31 Aug 2024 | 2,239 | 1,151,183 | - | 0.8 | 1,783 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.75 per share. | 31 Jul 2024 | 2,239 | 1,153,422 | - | 0.7 | 1,679 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.80 per share. | 30 Jun 2024 | 4,697 | 1,155,661 | - | 0.8 | 3,758 | Common Stock |
| Intuitive Surgical | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 1,359 | 216,644 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2024 | 1,359 | 4,074 | - | - | Restricted Stock Units - 6-12-23 | |
| Intuitive Surgical | David J. Rosa | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 417.61 per share. | 10 Jun 2024 | 689 | 215,955 (0%) | 0% | 417.6 | 287,733 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.93 per share. | 31 May 2024 | 2,239 | 1,160,358 | - | 0.9 | 2,082 | Common Stock |
| Intuitive Surgical | David J. Rosa | President | Gift of securities by or to the insider at price $ 0.00 per share. | 17 May 2024 | 2,507 | 215,285 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.13 per share. | 30 Apr 2024 | 2,239 | 1,162,597 | - | 1.1 | 2,530 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 21 Apr 2024 | 19,673 | 1,164,836 | - | 1.2 | 22,624 | Common Stock |
| Beacon Fin Corp | R. David Rosato | SEVP - Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.25 per share. | 01 Apr 2024 | 815 | 1,845 (0%) | 0% | 22.3 | 18,134 | Common Stock |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 31 Mar 2024 | 2,239 | 1,184,509 | - | 1.2 | 2,687 | Common Stock |
| Intuitive Surgical | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 2,253 | 218,193 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | Rosa J. David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 2,253 | 0 | - | - | Restricted Stock Units | |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.21 per share. | 29 Feb 2024 | 2,239 | 1,186,748 | - | 1.2 | 2,709 | Common Stock |
| Intuitive Surgical | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,504 | 3,007 | - | - | Restricted Stock Units | |
| Intuitive Surgical | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,504 | 218,555 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David Rosa J. | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.59 per share. | 29 Feb 2024 | 1,142 | 217,051 (0%) | 0% | 386.6 | 441,486 | Common Stock |
| Intuitive Surgical | Rosa J. David | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 386.59 per share. | 29 Feb 2024 | 763 | 217,792 (0%) | 0% | 386.6 | 294,968 | Common Stock |
| Intuitive Surgical | David Rosa J. | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 15,263 | 15,263 | - | - | Restricted Stock Units - 2-26-2024 | |
| Intuitive Surgical | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 1,710 | 1,710 | - | - | Restricted Stock Units | |
| Intuitive Surgical | Rosa David J. | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 1,710 | 216,807 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David Rosa J. | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 389.77 per share. | 26 Feb 2024 | 867 | 215,940 (0%) | 0% | 389.8 | 337,931 | Common Stock |
| NeuroOne Medical Tech Corp | David Rosa A. | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2024 | 663,497 | 1,188,987 | - | 0 | Common Stock | |
| BioRestorative Therapies Inc | David Rosa A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 79,646 | 79,646 | - | - | Stock Option | |
| Intuitive Surgical | J. Rosa David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 1,437 | 215,826 (0%) | 0% | 0 | Common Stock | |
| Intuitive Surgical | David Rosa J. | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 1,437 | 4,309 | - | - | Restricted Stock Units | |
| Intuitive Surgical | David J. Rosa | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 388.22 per share. | 10 Feb 2024 | 729 | 215,097 (0%) | 0% | 388.2 | 283,012 | Common Stock |
| Intuitive Surgical | Rosa David J. | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.09 per share. | 07 Feb 2024 | 40,500 | 225,084 (0%) | 0% | 49.1 | 1,988,100 | Common Stock |
| Intuitive Surgical | David Rosa J. | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 40,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical | J. Rosa David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 28,125 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.34 per share. | 07 Feb 2024 | 28,125 | 230,089 (0%) | 0% | 49.3 | 1,387,780 | Common Stock |
| Intuitive Surgical | David J. Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 28,125 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.02 per share. | 07 Feb 2024 | 28,125 | 200,734 (0%) | 0% | 51.0 | 1,434,814 | Common Stock |
| Intuitive Surgical | Rosa David J. | President | Sale of securities on an exchange or to another person at price $ 389.28 per share. | 07 Feb 2024 | 23,120 | 201,964 (0%) | 0% | 389.3 | 9,000,195 | Common Stock |
| Intuitive Surgical | Rosa J. David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.11 per share. | 07 Feb 2024 | 22,050 | 185,449 (0%) | 0% | 57.1 | 1,259,300 | Common Stock |
| Intuitive Surgical | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 22,050 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical | J. David Rosa | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.23 per share. | 07 Feb 2024 | 22,050 | 176,299 (0%) | 0% | 59.2 | 1,305,973 | Common Stock |
| Intuitive Surgical | J. Rosa David | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2024 | 22,050 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Intuitive Surgical | Rosa J. David | President | Sale of securities on an exchange or to another person at price $ 389.23 per share. | 07 Feb 2024 | 16,150 | 184,584 (0%) | 0% | 389.2 | 6,286,026 | Common Stock |
| Intuitive Surgical | David Rosa J. | President | Sale of securities on an exchange or to another person at price $ 389.29 per share. | 07 Feb 2024 | 15,700 | 214,389 (0%) | 0% | 389.3 | 6,111,784 | Common Stock |
| Intuitive Surgical | Rosa J. David | President | Sale of securities on an exchange or to another person at price $ 389.29 per share. | 07 Feb 2024 | 12,900 | 163,399 (0%) | 0% | 389.3 | 5,021,798 | Common Stock |
| Intuitive Surgical | J. David Rosa | President | Sale of securities on an exchange or to another person at price $ 389.30 per share. | 07 Feb 2024 | 12,840 | 172,609 (0%) | 0% | 389.3 | 4,998,665 | Common Stock |
| NeuroOne Medical Tech Corp | A. David Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.25 per share. | 31 Jan 2024 | 2,239 | 525,490 | - | 1.3 | 2,799 | Common Stock |
| Beacon Fin Corp | Rosato R. David | SEVP - Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2024 | 6,348 | 6,348 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | A. Rosa David | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. | 31 Dec 2023 | 2,239 | 527,729 | - | 1.6 | 3,538 | Common Stock |
| Intuitive Surgical | J. Rosa David | President | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2023 | 1,572 | 154,140 (0%) | 0% | 0 | Common Stock | |
| NeuroOne Medical Tech Corp | David A. Rosa | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. | 30 Nov 2023 | 2,239 | 529,968 | - | 1.5 | 3,247 | Common Stock |